• 

  The gut-brain axis: A key to metabolism and longevity

  How do our gut and brain communicate with one another, and how do they influence our metabolism, our behavior, and the aging process? Scripps Research neuroscience professor Supriya Srinivasan is dedicated to answering these pressing questions using modern genetic and molecular tools across different experimental systems. In this Front Row lecture, Srinivasan revealed the intricacies of the gut-brain networks that regulate energy regulation and fat metabolism, as well as their impact on lifespan. Discover how her work could lead to new therapies that restore a healthy metabolism and tackle dysregulation.

• 

  Front Row spotlight with Supriya Srinivasan

  How do our gut and brain communicate with one another, and how do they influence our metabolism, our behavior, and the aging process? Scripps Research neuroscience professor Supriya Srinivasan is dedicated to answering these pressing questions using modern genetic and molecular tools across different experimental systems. Srinivasan will reveal the intricacies of the gut-brain networks that regulate energy regulation and fat metabolism, as well as their impact on lifespan. Discover how her work could lead to new therapies that restore a healthy metabolism and tackle dysregulation.

• 

  Peering into the mitochondria to reveal cellular stress and disease

  The mitochondria are well known for being cellular “powerhouses,” given their important role in energy generation. Yet emerging research is now suggesting these organelles also play a key role as the stress-sensors for the cell. In this Front Row lecture, Scripps Research assistant professor Danielle Grotjahn explored how mitochondria change shape in response to different genetic and environmental stressors. By harnessing cutting-edge imaging technologies to examine mitochondria in these never-before-seen-ways, Grotjahn is revealing how these organelles can predict overall cellular health and even disease, including neurodegenerative disorders and cancer.

• 

  How do you feel? Molecules that sense touch and other pressures

  The inner workings of the brain have eluded neuroscientists for ages—including how we perceive sensations such as touch, pain, sound and even blood flow. In this Front Row lecture, Scripps Research professor and Nobel laureate Ardem Patapoutian discussed the molecular sensors that enable the mind to interpret different physical and chemical stimuli. These discoveries—for which Patapoutian was awarded the 2021 Nobel Prize in Physiology or Medicine—are helping answer long-standing questions in neuroscience, such as how cells communicate with each other, how we sense our body in time and space, how these sensors impact different diseases and more.

• 

  Delivering medicines for a global population

  Infectious diseases like tuberculosis and malaria pose an ever-increasing risk to communities around the world. Meanwhile, a lack of investment, long treatment protocols and drug resistance have stymied innovation in this area. In this Front Row lecture, Vice President of Medicinal Chemistry Arnab Chatterjee discussed how the Calibr-Skaggs Institute of Innovative Medicines—the drug discovery and development arm of Scripps Research—is using innovative new approaches and technologies to overcome these historic barriers. His work at the Calibr-Skaggs Institute is helping accelerate the delivery of safe, effective and accessible medicines to countries spanning the globe.

• 

  Regenerating tissues to treat disease

  Regenerative medicine involves harnessing the body’s own capacity to repair tissues and organs. In this Front Row lecture, Associate Professor Michael Bollong shared how he's identifying and targeting the pathways controlling regeneration. By combining traditional drug discovery tools with modern biological techniques, Bollong and his lab are developing novel medicines that can intervene in the processes that cause a spectrum of human diseases and medical conditions, including heart disease, inflammatory disease and fibrosis.

• 

  Fixing the misfolded proteins that cause dementia and heart failure

  All proteins have a correct way of “folding” themselves into their 3D structures. When this folding process goes awry, including processes leading to protein misassembly, a number of devastating diseases can result. In this Front Row lecture, Scripps Research professor Jeffery Kelly shared how he's developing novel therapeutic strategies to target these protein misfolding diseases, which lead to deterioration of the heart and brain. His multi-disciplinary research has already led to the development of an FDA-approved drug available in the pharmacy called tafamidis (Vyndaqel® and Vyndamax®): a medicine that slows the progression of the neurodegenerative disease familial amyloid polyneuropathy and the degenerative heart disease called TTR cardiomyopathy.

• 

  Front Row spotlight with Jeffery Kelly

  Scripps Research professor Jeffery Kelly received an unexpected visit from a patient whose life was dramatically improved by tafamidis—a revolutionary drug for treating neurodegenerative and heart diseases, developed by Kelly himself. Kelly is a leading figure at Scripps Research, spearheading efforts to address some of the most pressing medical challenges, including Alzheimer’s and various amyloid diseases. His cutting-edge research on protein misfolding has not only led to the development of tafamidis but has also broadened our understanding of protein aggregation disorders.

• 

  Bringing precision therapy to mental disorders

  Mental disorders like depression and schizophrenia affect the lives of millions of people around the world, and yet, available treatment options have remained the same for decades. In this Front Row lecture, Scripps Research professor Hugh Rosen shared how his pioneering research has led to the development of the drug navacaprant, which precisely targets one of the brain’s behavioral circuits and is currently in clinical testing for major depressive disorder. Harnessing his expertise as a physician-scientist, Rosen has discovered and developed multiple other medicines, including ozanimod—a breakthrough treatment approved for multiple sclerosis and ulcerative colitis.

• 

  How experiences shape the developing brain and impact neurological diseases

  As we age, learn and grow over our lifetimes, the brain continually responds and adapts to what we experience. In this Front Row lecture, Scripps Research Chair of the Department of Neuroscience Hollis Cline revealed how sensory experiences shape the brain during development and aging—particularly visual experiences. Cline’s work has been critical in revealing how key visual brain circuits become disrupted in neurodevelopmental disorders, as well as in mapping the different communication pathways between neurons.